LOGIN  |  REGISTER
C4 Therapeutics

Recent Insider Transactions - Humacyte (NASDAQ: HUMA)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ HUMA Humacyte
Niklason Laura E / director, officer: President, CEO and Director
12/19/2024
Buy
$10.28
525
$5K
2,625
NASDAQ HUMA Humacyte
Sander Dale A. / officer: CFO and Chief Corp. Deve. Off.
12/19/2024
Buy
$10.28
525
$5K
2,625
NASDAQ HUMA Humacyte
Prichard Heather Ledbetter / officer: Chief Operating Officer
12/19/2024
Buy
$10.28
525
$5K
2,625
NASDAQ HUMA Humacyte
Dougan Brady W / director
12/19/2024
Buy
$10.28
525
$5K
2,625
NASDAQ HUMA Humacyte
Constantino Michael T. / director
12/04/2024
Buy
$4.39
4,600
$20K
16,950
NASDAQ HUMA Humacyte
Niklason Laura E / director, officer: President, CEO and Director
11/19/2024
Buy
$4.44
1,797
$8K
243,851
NASDAQ HUMA Humacyte
Dougan Brady W / director
11/19/2024
Buy
$4.44
1,797
$8K
243,851
NASDAQ HUMA Humacyte
Niklason Laura E / director, officer: President, CEO and Director
11/18/2024
Sell
$4.44
811,172
$3.602M
2.42M
NASDAQ HUMA Humacyte
Niklason Laura E / director, officer: President, CEO and Director
11/19/2024
Sell
$4.34
427,459
$1.855M
1.99M
NASDAQ HUMA Humacyte
Niklason Laura E / director, officer: President, CEO and Director
11/20/2024
Sell
$4.40
261,369
$1.150M
1.73M
NASDAQ HUMA Humacyte
Dougan Brady W / director
11/18/2024
Sell
$4.44
811,172
$3.602M
2.42M
NASDAQ HUMA Humacyte
Dougan Brady W / director
11/19/2024
Sell
$4.34
427,459
$1.855M
1.99M
NASDAQ HUMA Humacyte
Dougan Brady W / director
11/20/2024
Sell
$4.40
261,369
$1.150M
1.73M

COPYRIGHT ©2023 HEALTH STOCKS HUB